UPDATE 1-Physicians Formula gets rival buyout proposal

Thu Sep 6, 2012 4:38pm IST

Stocks

   

* Receives new offer at $4.90 per share

* Swander Pace had offered $4.25 per share

* New offer at a premium of 12 pct to Wednesday close

* Co says not yet determined bid as superior

Sept 6 (Reuters) - Cosmetics company Physicians Formula Holdings Inc, which in August agreed to go private with Swander Pace Capital, said it received a rival buyout offer of about $67.2 million from an unnamed party.

The new unsolicited, non-binding offer of $4.90 per share is at a 12 percent premium to Physicians Formula's Wednesday close of $4.37. Swander Pace had agreed to pay Physicians Formula shareholders $4.25 per share in cash.

Physicians Formula, which is evaluating the new proposal, said its board has not yet determined that the bid is superior to Swander Pace's proposal.

Founded in 1937, Physicians Formula sells high-priced cosmetics and skin care products at chains owned by Wal-Mart Stores Inc, Target Corp and Rite Aid Corp .

Shares of Physicians Formula, which has a market capitalization of about $60 million, have risen 19 percent since the Swander Pace deal was announced.

Monetary Policy Committee

Reuters Showcase

Microfinance

Microfinance

Funding the unfunded: India helps small business borrow to grow  Full Article 

Insurance Sector

Insurance Sector

UK healthcare firm Bupa sees strong growth in India  Full Article 

Sensex Rises

Sensex Rises

Sensex edges up; consumer and healthcare stocks rise  Full Article 

Market Eye

Market Eye

FTSE adds nine Indian firms as large-caps in Asia-Pacific ex-Japan index   Full Article 

Indian Ocean Diplomacy

Indian Ocean Diplomacy

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

ECB Bond-Buying

ECB Bond-Buying

ECB raises growth forecasts, to start printing money next week  Full Article 

China Economy

China Economy

China signals "new normal" with lower annual growth target  Full Article 

Pharma Sector

Pharma Sector

Panel recommends waiving late-stage trials for some drugs  Full Article 

E-commerce

E-commerce

China backs e-commerce expansion in win for Alibaba, JD.com  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage